Peringatan Keamanan

Ioversol overdosage causes life-threatening adverse effects, mainly in the pulmonary and cardiovascular system.L41780 In case of an overdose, treatment must focus on the support of vital functions and the prompt institution of symptomatic therapy.L41785 The carcinogenic potential of ioversol has not been evaluated, and non-clinical studies suggest that ioversol is not mutagenic and does not affect fertility.L41780 The LD50 values in mice and rats are 17 g/kg and 15 g/kg respectively. Developmental toxicity studies were carried out in rats (gestation day 7 to 17) and rabbits (gestation day 6 to 18) given ioversol at the following intravenous doses: 0, 0.2, 0.8, and 3.2 g iodine/kg/day. Adverse effects on embryo-fetal development were not detected in either species, while maternal toxicity was detected in rabbits at 0.8, and 3.2 g iodine/kg/day.L41780

Serious adverse reactions have been reported due to the inadvertent intrathecal administration of iodinated contrast media that are not indicated for intrathecal use such as ioversol. These serious adverse reactions include death, convulsions, cerebral hemorrhage, coma, paralysis, arachnoiditis, acute renal failure, cardiac arrest, seizures, rhabdomyolysis, hyperthermia, and brain edema.L41780 Caution must be exercised in patients with severely impaired renal function, combined renal and hepatic disease, severe thyrotoxicosis, myelomatosis, or anuria, particularly when large doses are administered.L41785

Ioversol

DB09134

small molecule approved

Deskripsi

Ioversol is a non-ionic compound with a tri-iodinated benzene ring used as a contrast dye in diagnostic procedures to visualize different types of organs and tissues.L41780 Iodine has a high atomic density, which gives it the ability to attenuate X-rays.L41790 The intravascular administration of iodine compounds, such as ioversol, enhances the contrast between vessels in the path of the flow of the contrast medium and normal tissue, allowing the visualization of internal structures.L41780 Ioversol is a highly hydrophilic agent considered to be generally safeL41790; however, serious adverse reactions have been reported due to the inadvertent intrathecal administration of ioversol, which is only indicated for intra-arterial and intravenous use.L41780

Ioversol was approved by the FDA in 1989 and is currently indicated for computed tomographic (CT) imaging and contrast enhancement in peripheral arteriography, coronary arteriography, and left ventriculography.L41780,L41790

Struktur Molekul 2D

Berat 807.115
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) The elimination half-life was 1.5 hr in healthy volunteers (n=12) receiving 50 and 150 mL of ioversol 68%.[L41780] In patients with renal dysfunction, the elimination half-life of ioversol is prolonged.[L41785]
Volume Distribusi In adults, the volume of distribution of ioversol was 0.26 L/kg body weight, consistent with its extracellular space distribution[L41780].
Klirens (Clearance) In healthy volunteers that received 50 mL of ioversol, clearance was 156 mL/min, and in those receiving 150 mL of ioversol, clearance was 185 mL/min.[A248450]

Absorpsi

Healthy volunteers that received 50 and 150 mL of ioversol, had a corresponding Cmax of 1.45 mg/mL and 2.36 mg/mL and a corresponding tmax of 2.0 min and 4.3 min.A248450 AUC was 1.74 mg?hr/mL in healthy volunteers that received 50 mL of ioversol, and 4.43 mg?hr/mL in those that received 150 mL.A248450 The pharmacokinetics of ioversol follow an open two compartment model with first-order elimination.L41785 Since ioversol is almost completely excreted by the kidney as a parent drug, patients with renal impairment are expected to have a lower elimination rate.L41780

Metabolisme

Ioversol does not undergo significant metabolism, deiodination or biotransformation.L41780

Rute Eliminasi

Following intravascular administration, ioversol is excreted mainly through the kidneys.L41785 Within the first 24 hours, more than 95% of the administered dose is excreted. Urine concentration peaks in the first 2 hours after ioversol is administered.L41780 Fecal elimination is negligible.L41785

Interaksi Obat

728 Data
Aldesleukin The risk of a hypersensitivity reaction to Ioversol is increased when it is combined with Aldesleukin.
Metformin The risk or severity of adverse effects can be increased when Ioversol is combined with Metformin.
Cyclosporine Cyclosporine may decrease the excretion rate of Ioversol which could result in a higher serum level.
Icosapent Icosapent may decrease the excretion rate of Ioversol which could result in a higher serum level.
Cefotiam Cefotiam may decrease the excretion rate of Ioversol which could result in a higher serum level.
Mesalazine Mesalazine may decrease the excretion rate of Ioversol which could result in a higher serum level.
Cefmenoxime Cefmenoxime may decrease the excretion rate of Ioversol which could result in a higher serum level.
Cefmetazole Cefmetazole may decrease the excretion rate of Ioversol which could result in a higher serum level.
Pamidronic acid Pamidronic acid may decrease the excretion rate of Ioversol which could result in a higher serum level.
Tenofovir disoproxil Tenofovir disoproxil may decrease the excretion rate of Ioversol which could result in a higher serum level.
Indomethacin Indomethacin may decrease the excretion rate of Ioversol which could result in a higher serum level.
Cidofovir Cidofovir may decrease the excretion rate of Ioversol which could result in a higher serum level.
Cefpiramide Cefpiramide may decrease the excretion rate of Ioversol which could result in a higher serum level.
Ceftazidime Ceftazidime may decrease the excretion rate of Ioversol which could result in a higher serum level.
Loracarbef Loracarbef may decrease the excretion rate of Ioversol which could result in a higher serum level.
Cefalotin Cefalotin may decrease the excretion rate of Ioversol which could result in a higher serum level.
Nabumetone Nabumetone may decrease the excretion rate of Ioversol which could result in a higher serum level.
Ketorolac Ketorolac may decrease the excretion rate of Ioversol which could result in a higher serum level.
Tenoxicam Tenoxicam may decrease the excretion rate of Ioversol which could result in a higher serum level.
Celecoxib Celecoxib may decrease the excretion rate of Ioversol which could result in a higher serum level.
Cefotaxime Cefotaxime may decrease the excretion rate of Ioversol which could result in a higher serum level.
Tolmetin Tolmetin may decrease the excretion rate of Ioversol which could result in a higher serum level.
Foscarnet Foscarnet may decrease the excretion rate of Ioversol which could result in a higher serum level.
Rofecoxib Rofecoxib may decrease the excretion rate of Ioversol which could result in a higher serum level.
Piroxicam Piroxicam may decrease the excretion rate of Ioversol which could result in a higher serum level.
Methotrexate Methotrexate may decrease the excretion rate of Ioversol which could result in a higher serum level.
Cephalexin Cephalexin may decrease the excretion rate of Ioversol which could result in a higher serum level.
Fenoprofen Fenoprofen may decrease the excretion rate of Ioversol which could result in a higher serum level.
Valaciclovir Valaciclovir may decrease the excretion rate of Ioversol which could result in a higher serum level.
Valdecoxib Valdecoxib may decrease the excretion rate of Ioversol which could result in a higher serum level.
Diclofenac Diclofenac may decrease the excretion rate of Ioversol which could result in a higher serum level.
Sulindac Sulindac may decrease the excretion rate of Ioversol which could result in a higher serum level.
Bacitracin Bacitracin may decrease the excretion rate of Ioversol which could result in a higher serum level.
Amphotericin B Amphotericin B may decrease the excretion rate of Ioversol which could result in a higher serum level.
Cephaloglycin Cephaloglycin may decrease the excretion rate of Ioversol which could result in a higher serum level.
Flurbiprofen Flurbiprofen may decrease the excretion rate of Ioversol which could result in a higher serum level.
Adefovir dipivoxil Adefovir dipivoxil may decrease the excretion rate of Ioversol which could result in a higher serum level.
Pentamidine Pentamidine may decrease the excretion rate of Ioversol which could result in a higher serum level.
Etodolac Etodolac may decrease the excretion rate of Ioversol which could result in a higher serum level.
Mefenamic acid Mefenamic acid may decrease the excretion rate of Ioversol which could result in a higher serum level.
Acyclovir Acyclovir may decrease the excretion rate of Ioversol which could result in a higher serum level.
Naproxen Naproxen may decrease the excretion rate of Ioversol which could result in a higher serum level.
Sulfasalazine Sulfasalazine may decrease the excretion rate of Ioversol which could result in a higher serum level.
Phenylbutazone Phenylbutazone may decrease the excretion rate of Ioversol which could result in a higher serum level.
Meloxicam Meloxicam may decrease the excretion rate of Ioversol which could result in a higher serum level.
Carprofen Carprofen may decrease the excretion rate of Ioversol which could result in a higher serum level.
Cefaclor Cefaclor may decrease the excretion rate of Ioversol which could result in a higher serum level.
Diflunisal Diflunisal may decrease the excretion rate of Ioversol which could result in a higher serum level.
Tacrolimus Tacrolimus may decrease the excretion rate of Ioversol which could result in a higher serum level.
Ceforanide Ceforanide may decrease the excretion rate of Ioversol which could result in a higher serum level.
Salicylic acid Salicylic acid may decrease the excretion rate of Ioversol which could result in a higher serum level.
Meclofenamic acid Meclofenamic acid may decrease the excretion rate of Ioversol which could result in a higher serum level.
Acetylsalicylic acid Acetylsalicylic acid may decrease the excretion rate of Ioversol which could result in a higher serum level.
Carboplatin Carboplatin may decrease the excretion rate of Ioversol which could result in a higher serum level.
Oxaprozin Oxaprozin may decrease the excretion rate of Ioversol which could result in a higher serum level.
Ketoprofen Ketoprofen may decrease the excretion rate of Ioversol which could result in a higher serum level.
Balsalazide Balsalazide may decrease the excretion rate of Ioversol which could result in a higher serum level.
Ibuprofen Ibuprofen may decrease the excretion rate of Ioversol which could result in a higher serum level.
Cefditoren Cefditoren may decrease the excretion rate of Ioversol which could result in a higher serum level.
Atazanavir Atazanavir may decrease the excretion rate of Ioversol which could result in a higher serum level.
Colistimethate Colistimethate may decrease the excretion rate of Ioversol which could result in a higher serum level.
Cefuroxime Cefuroxime may decrease the excretion rate of Ioversol which could result in a higher serum level.
Cefapirin Cefapirin may decrease the excretion rate of Ioversol which could result in a higher serum level.
Cefadroxil Cefadroxil may decrease the excretion rate of Ioversol which could result in a higher serum level.
Cefprozil Cefprozil may decrease the excretion rate of Ioversol which could result in a higher serum level.
Ceftriaxone Ceftriaxone may decrease the excretion rate of Ioversol which could result in a higher serum level.
Olsalazine Olsalazine may decrease the excretion rate of Ioversol which could result in a higher serum level.
Lumiracoxib Lumiracoxib may decrease the excretion rate of Ioversol which could result in a higher serum level.
Cefamandole Cefamandole may decrease the excretion rate of Ioversol which could result in a higher serum level.
Cefazolin Cefazolin may decrease the excretion rate of Ioversol which could result in a higher serum level.
Cefonicid Cefonicid may decrease the excretion rate of Ioversol which could result in a higher serum level.
Cefoperazone Cefoperazone may decrease the excretion rate of Ioversol which could result in a higher serum level.
Cefotetan Cefotetan may decrease the excretion rate of Ioversol which could result in a higher serum level.
Cefoxitin Cefoxitin may decrease the excretion rate of Ioversol which could result in a higher serum level.
Ceftizoxime Ceftizoxime may decrease the excretion rate of Ioversol which could result in a higher serum level.
Cefradine Cefradine may decrease the excretion rate of Ioversol which could result in a higher serum level.
Magnesium salicylate Magnesium salicylate may decrease the excretion rate of Ioversol which could result in a higher serum level.
Salsalate Salsalate may decrease the excretion rate of Ioversol which could result in a higher serum level.
Choline magnesium trisalicylate Choline magnesium trisalicylate may decrease the excretion rate of Ioversol which could result in a higher serum level.
Cefepime Cefepime may decrease the excretion rate of Ioversol which could result in a higher serum level.
Cefacetrile Cefacetrile may decrease the excretion rate of Ioversol which could result in a higher serum level.
Ceftibuten Ceftibuten may decrease the excretion rate of Ioversol which could result in a higher serum level.
Cefpodoxime Cefpodoxime may decrease the excretion rate of Ioversol which could result in a higher serum level.
Antrafenine Antrafenine may decrease the excretion rate of Ioversol which could result in a higher serum level.
Aminophenazone Aminophenazone may decrease the excretion rate of Ioversol which could result in a higher serum level.
Antipyrine Antipyrine may decrease the excretion rate of Ioversol which could result in a higher serum level.
Tiaprofenic acid Tiaprofenic acid may decrease the excretion rate of Ioversol which could result in a higher serum level.
Lopinavir Lopinavir may decrease the excretion rate of Ioversol which could result in a higher serum level.
Etoricoxib Etoricoxib may decrease the excretion rate of Ioversol which could result in a higher serum level.
Hydrolyzed Cephalothin Hydrolyzed Cephalothin may decrease the excretion rate of Ioversol which could result in a higher serum level.
Cephalothin Group Cephalothin Group may decrease the excretion rate of Ioversol which could result in a higher serum level.
Oxyphenbutazone Oxyphenbutazone may decrease the excretion rate of Ioversol which could result in a higher serum level.
Latamoxef Latamoxef may decrease the excretion rate of Ioversol which could result in a higher serum level.
Nimesulide Nimesulide may decrease the excretion rate of Ioversol which could result in a higher serum level.
Benoxaprofen Benoxaprofen may decrease the excretion rate of Ioversol which could result in a higher serum level.
Metamizole Metamizole may decrease the excretion rate of Ioversol which could result in a higher serum level.
Zomepirac Zomepirac may decrease the excretion rate of Ioversol which could result in a higher serum level.
Ceftobiprole Ceftobiprole may decrease the excretion rate of Ioversol which could result in a higher serum level.
Cimicoxib Cimicoxib may decrease the excretion rate of Ioversol which could result in a higher serum level.
Ceftaroline fosamil Ceftaroline fosamil may decrease the excretion rate of Ioversol which could result in a higher serum level.

Referensi & Sumber

Synthesis reference: Bailey, AR., et al. (1993). Synthesis of ioversol (U.S. Patent No. 5,489,708). U.S. Patent and Trademark Office. https://patentimages.storage.googleapis.com/74/66/8e/1eddf38cd8cd41/US5489708.pdf
Artikel (PubMed)
  • PMID: 2793391
    Wilkins RA, Whittington JR, Brigden GS, Lahiri A, Heber ME, Hughes LO: Safety and pharmacokinetics of ioversol in healthy volunteers. Invest Radiol. 1989 Oct;24(10):781-8. doi: 10.1097/00004424-198910000-00011.

Contoh Produk & Brand

Produk: 16 • International brands: 3
Produk
  • Optiray 160
    Injection • 339 mg/1mL • Intravascular • US • Approved
  • Optiray 160
    Solution • 34 % • Intravenous • Canada • Approved
  • Optiray 160 (ultraject)
    Solution • 34 % • Intravascular • Canada • Approved
  • Optiray 240
    Injection • 509 mg/1mL • Intra-arterial; Intravenous • US • Approved
  • Optiray 240
    Solution • 51 % w/v • Intravascular; Subarachnoid • Canada • Approved
  • Optiray 240 (ultraject)
    Solution • 51 % w/v • Intravascular; Subarachnoid • Canada • Approved
  • Optiray 240 Inj 240mg/ml
    Liquid • 240 mg / mL • Intravascular • Canada • Approved
  • Optiray 300
    Injection • 636 mg/1mL • Intra-arterial; Intravenous • US • Approved
Menampilkan 8 dari 16 produk.
International Brands
  • OPTIRAY 300 — Liebel-Flarsheim
  • OPTIRAY 320 — Liebel-Flarsheim
  • OPTIRAY 350 — Liebel-Flarsheim

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul